All Access Pass - 1 FREE Month!
Institutional email required, no credit card necessary.
Lung Cancer for the Nurse Practitioner Licensing Exam
Lung Cancer Overview
  • Epidemiology:
    • Lung cancer is the leading cause of cancer-related death globally.
    • Most common in individuals over 50 and is strongly associated with smoking.
  • Risk Factors:
    • Smoking: Primary risk factor, with greater risk linked to higher pack-years.
    • Environmental Exposures: Radon, asbestos, air pollution, and secondhand smoke.
    • Genetic Factors: Family history and mutations in genes such as EGFR and KRAS.
Types of Lung Cancer
  • Non-Small Cell Lung Cancer (NSCLC) (~85% of cases):
    • Adenocarcinoma: Most common type, particularly in nonsmokers and women; often peripheral.
Adenocarcinoma Lung Cancer
    • Squamous Cell Carcinoma: Linked to smoking, typically central, and may cavitate.
    • Large Cell Carcinoma: Rare, usually peripheral, and associated with rapid growth.
  • Small Cell Lung Cancer (SCLC) (~15% of cases):
    • Highly aggressive and strongly associated with smoking; tends to be central.
    • Commonly presents with paraneoplastic syndromes such as SIADH and ectopic ACTH production.
Clinical Presentation
  • Respiratory Symptoms:
    • Cough: Persistent and progressive.
    • Hemoptysis: Especially with central tumors.
    • Dyspnea: From tumor obstruction, effusion, or lung parenchymal involvement.
    • Chest Pain: Dull and often worsens with deep breathing.
  • Systemic Symptoms:
    • Weight Loss and Fatigue: Common in advanced disease due to metabolic demands of the tumor.
  • Paraneoplastic Syndromes:
    • SIADH: Causes hyponatremia, more common in SCLC.
    • Hypercalcemia: Seen in squamous cell carcinoma due to PTHrP secretion.
Diagnostic Evaluation
  • Imaging:
    • Chest X-ray: First-line; may show mass, nodule, or pleural effusion.
    • CT Scan: Defines tumor size, location, and extent of disease.
  • Biopsy:
    • Bronchoscopy or CT-Guided Needle Biopsy: Used for tissue diagnosis.
Treatment
  • NSCLC:
    • Surgery: First-line in early stages (Stage I-II).
    • Radiation: For non-surgical candidates or advanced disease.
    • Chemotherapy: Used in later stages or as adjuvant therapy.
  • SCLC:
    • Primarily treated with chemotherapy and radiation, as it typically presents at an advanced stage.
Key Points
  • Lung cancer, mostly due to smoking, is the leading cause of cancer death.
  • NSCLC is the more common type, with adenocarcinoma often found in nonsmokers and females.
  • SCLC is aggressive, frequently presenting with paraneoplastic syndromes like SIADH.
  • Diagnosis requires imaging (X-ray, CT) and biopsy.
  • Treatment depends on the type and stage, with surgery for early-stage NSCLC and chemotherapy/radiation for advanced disease or SCLC.